News

Reportedly, in the planned phase 2 trial, approximately 20 patients who have failed treatment with first-line agents will be administered daily oral doses of Bafetinib. In the study,

The company is currently in discussions with a number of governments regarding their specific pandemic planning needs, including governments who are changing their planned immunisation programs. GSK confirmed

The company said that Davunetide’s potential as a treatment for PSP was confirmed in both animal studies and phase II human clinical trials in patients with amnestic mild

Taliglucerase alfa is the company’s proprietary plant cell expressed recombinant form of glucocerebrosidase for the treatment of Gaucher disease. The FDA has granted orphan drug designation and fast

Goldman Sachs said: “India presents an attractive region for clinical trials given a population of over one billion, a large number of English-speaking patients, and a well developed

In May 2006, Mannatech filed a lawsuit against Techmedica and Ionx in the US District Court for the Northern District of Texas, Dallas Division, alleging infringement of its

Cardiac Science, with an installed customer base of more than 65,000 diagnostic monitoring devices, can connect its devices with Medent systems for a smooth transfer of test results.

Cell-IQ, developed by Finnish company, Chip-Man Technologies, is already being successfully employed in prestigious universities and institutes across Europe and Asia, and is now exclusively available via TAP

The first antibody conjugate is Nimotuzumab coupled to a radionuclide, indium-111, and a cell-nucleus delivery system developed in the laboratory of Dr. Raymond Reilly, Professor, Leslie Dan Faculty